Koklic Tilen, Majumder Rinku, Lentz Barry R
*Department of Biochemistry and Biophysics, CB#7260, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7260, U.S.A.
Biochem J. 2014 Sep 15;462(3):591-601. doi: 10.1042/BJ20140130.
Calcium (Ca2+) plays a pivotal role in cellular and organismal physiology. The Ca2+ ion has an intermediate protein-binding affinity and thus it can serve as an on/off switch in the regulation of different biochemical processes. The serum level of ionized Ca2+ is regulated with normal ionized Ca2+ being in the range 1.10-1.3 mM. Hypocalcaemia (free Ca2+<1.1 mM) in critically ill patients is commonly accompanied by haemostatic abnormalities, ranging from isolated thrombocytopenia to complex defects such as disseminated intravascular coagulation, commonly thought to be due to insufficient functioning of anticoagulation pathways. A small amount of fXa (Factor Xa) produced by Factor VIIa and exposed tissue factor is key to initiating blood coagulation by producing enough thrombin to induce the later stages of coagulation. fXa must bind to PS (phosphatidylserine)-containing membranes to produce thrombin at a physiologically significant rate. In the present study, we show that overall fXa activity on PS-containing membranes is sharply regulated by a 'Ca2+ switch' centred at 1.16 mM, below which fXa is active and above which fXa forms inactive dimers on PS-exposing membranes. Our data lead to a mathematical model that predicts the variation of fXa activity as a function of both Ca2+ and membrane concentrations. Because the critical Ca2+ concentration is at the lower end of the normal plasma ionized Ca2+ concentration range, we propose a new regulatory mechanism by which local Ca2+ concentration switches fXa from an intrinsically active form to a form requiring its cofactor [fVa (Factor Va)] to achieve significant activity.
钙(Ca2+)在细胞和机体生理过程中起着关键作用。Ca2+离子具有中等的蛋白质结合亲和力,因此它可以作为不同生化过程调节中的开/关开关。血清中离子化Ca2+的水平受到调节,正常离子化Ca2+的范围在1.10 - 1.3 mM之间。危重症患者的低钙血症(游离Ca2+<1.1 mM)通常伴有止血异常,范围从单纯的血小板减少到复杂的缺陷,如弥散性血管内凝血,通常认为这是由于抗凝途径功能不足所致。由因子VIIa和暴露的组织因子产生的少量因子Xa(fXa)是启动血液凝固的关键,它通过产生足够的凝血酶来诱导凝血的后期阶段。fXa必须与含磷脂酰丝氨酸(PS)的膜结合,才能以生理上显著的速率产生凝血酶。在本研究中,我们表明,含PS膜上的总体fXa活性受到以1.16 mM为中心的“Ca2+开关”的严格调节,低于该浓度时fXa具有活性,高于该浓度时fXa在暴露PS的膜上形成无活性的二聚体。我们的数据导出了一个数学模型,该模型预测fXa活性随Ca2+和膜浓度的变化。由于临界Ca2+浓度处于正常血浆离子化Ca2+浓度范围的下限,我们提出了一种新的调节机制,即局部Ca2+浓度将fXa从内在活性形式转变为需要其辅因子[fVa(因子Va)]才能实现显著活性的形式。